&nbsp;

HPV-Postcards-other-languages.zip

New

Nov 2025

Document

HPV-Posters-other-languages.zip

New

Nov 2025

Document

HPV_Postcards-other-languages.zip

New

Nov 2025

Document

DataTablesErrata.xlsx

New

Nov 2025

Document

DataFigures-Erratta.xlsx

New

Nov 2025

Regimen

NIVL+RELA

Cancer Type:

Skin,

Melanoma

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab and Relatlimab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Drugs Used:

nivolumab / relatlimab

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

BORTDEXALENA+ISAT; DEXALENA+ISAT(MNT)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Previously Untreated - Multiple Myeloma

ODB - General Benefit

dexamethasone

Drugs Used:

isatuximab (Compassionate),

bortezomib,

dexamethasone,

lenalidomide (Unfunded)

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

BORTDEXA+BELA; BELA(MNT)

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

New Drug Funding Program

Bortezomib - Relapsed or Refractory Multiple Myeloma

ODB - General Benefit

dexamethasone

Drugs Used:

belantamab mafodotin (Compassionate),

bortezomib,

dexamethasone

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen

DEXAPOMA+BELA

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

belantamab mafodotin (Compassionate),

pomalidomide (Unfunded),

dexamethasone

Quick Link(s):

Regimen Monograph

Nov 2025

Regimen Requests

Document

Errata-Tables

New

Nov 2025

Document